FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
--------------------------------------------------------------------
Source: CNBC
Published: 2026-03-19 04:17 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Food & Agriculture, Drugs
--------------------------------------------------------------------
Snippet:
Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.
--------------------------------------------------------------------